Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 2/2015

01.04.2015 | Original Article

Buccal Versus Vaginal Misoprostol Administration for the Induction of First and Second Trimester Abortions

verfasst von: Geetika Garg, Medical Officer, Navneet Takkar, Associate Professor, Alka Sehgal, Associate Professor

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To compare the effectiveness, side effects, and patient satisfaction of buccal versus vaginal misoprostol administration in first and second trimester induced abortions.

Methods

In first trimester, women received oral mifepristone followed by misoprostol either by buccal or vaginal route. In second trimester, women received oral mifepristone followed by repeated doses of misoprostol either by buccal or vaginal route. A comparative analysis using SPSS was done.

Results

In first trimester, success rate of medical abortion was 96 % in buccal group and 88 % in vaginal group. Nausea was the most common adverse effect which was similar in both groups. In second trimester, success rate was 96 % in buccal group and 80 % in vaginal group. A statistically higher incidence of nausea was noticed in buccal group. Patient satisfaction level was almost similar in both the groups in both trimesters.

Conclusions

Buccal and vaginal routes of misoprostol administration have similar efficacy and patient satisfaction level for first and second trimester induced abortions. Hence, buccal route may serve as an alternative to vaginal misoprostol.
Literatur
1.
Zurück zum Zitat Medical Termination of Pregnancy act. MTP act (1971) and MTP rule (1972): Govt. of India. Medical Termination of Pregnancy act. MTP act (1971) and MTP rule (1972): Govt. of India.
2.
Zurück zum Zitat Lohr PA, Reeves MF, Hayes JL, et al. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study. Contraception. 2007;76:215–20.CrossRefPubMed Lohr PA, Reeves MF, Hayes JL, et al. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study. Contraception. 2007;76:215–20.CrossRefPubMed
3.
Zurück zum Zitat Middleton T, Schaff E, Fielding SL, et al. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception. 2005;72:328–32.CrossRefPubMed Middleton T, Schaff E, Fielding SL, et al. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception. 2005;72:328–32.CrossRefPubMed
4.
Zurück zum Zitat Schaff EA, DiCenzo R, Fielding SL. Comparison of misoprostol plasma concentrations following buccal and sublingual administration. Contraception. 2005;71:22–5.CrossRefPubMed Schaff EA, DiCenzo R, Fielding SL. Comparison of misoprostol plasma concentrations following buccal and sublingual administration. Contraception. 2005;71:22–5.CrossRefPubMed
5.
Zurück zum Zitat Medical management of first-trimester abortion. Practice Bulletin No. 143. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2014;123:676–92.CrossRef Medical management of first-trimester abortion. Practice Bulletin No. 143. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2014;123:676–92.CrossRef
6.
Zurück zum Zitat Fjerstad M, Sinin I, Lichtenberg ES, et al. Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days. Contraception. 2009;80:282–6.CrossRefPubMedCentralPubMed Fjerstad M, Sinin I, Lichtenberg ES, et al. Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days. Contraception. 2009;80:282–6.CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Wildschut H, Both MI, Medema S, et al. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev. 2011;2:CD005216. Wildschut H, Both MI, Medema S, et al. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev. 2011;2:CD005216.
8.
Zurück zum Zitat WHO. Safe abortion: technical and policy guidance for health systems. Geneva: WHO; 2003. WHO. Safe abortion: technical and policy guidance for health systems. Geneva: WHO; 2003.
9.
Zurück zum Zitat RCOG. The care of women requesting induced abortion. London: Royal College of Obstetricians and Gynaecologists; 2004. RCOG. The care of women requesting induced abortion. London: Royal College of Obstetricians and Gynaecologists; 2004.
10.
Zurück zum Zitat Ellis SC, Kapp N, Vragpvoc O, et al. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion. Contraception. 2010;81:441–5.CrossRefPubMed Ellis SC, Kapp N, Vragpvoc O, et al. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion. Contraception. 2010;81:441–5.CrossRefPubMed
11.
Zurück zum Zitat Daponte A, Nzewenga G, Dimopoulos KD, et al. The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section. Contraception. 2006;74:324–7.CrossRefPubMed Daponte A, Nzewenga G, Dimopoulos KD, et al. The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section. Contraception. 2006;74:324–7.CrossRefPubMed
12.
Zurück zum Zitat Berghella V, Airoldi J, O’Neill AM, et al. Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review. BJOG. 2009;116(9):1151–7.CrossRefPubMed Berghella V, Airoldi J, O’Neill AM, et al. Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review. BJOG. 2009;116(9):1151–7.CrossRefPubMed
Metadaten
Titel
Buccal Versus Vaginal Misoprostol Administration for the Induction of First and Second Trimester Abortions
verfasst von
Geetika Garg, Medical Officer
Navneet Takkar, Associate Professor
Alka Sehgal, Associate Professor
Publikationsdatum
01.04.2015
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 2/2015
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-014-0605-5

Weitere Artikel der Ausgabe 2/2015

The Journal of Obstetrics and Gynecology of India 2/2015 Zur Ausgabe

Instrument Review

EZ Clamp

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.